Michel Farnier
- Surgery top 0.2%
- Economics and Econometrics top 0.5%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Cardiology and Cardiovascular Medicine top 2%
- Cancer Research top 2%
- Co-authors
- John J.P. KasteleinMichel KrempfGisle LangsletChristelle LorenzatoJennifer G. RobinsonMaurizio AvernaRobert PordyUmesh Chaudhari
- Topics
- Lipoproteins and Cardiovascular Health (161 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (59 papers)Cancer, Lipids, and Metabolism (45 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Michel Farnier
190 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Surgery 4.9k
- Economics and Econometrics 1.8k
- Endocrinology, Diabetes and Metabolism 1.7k
- Cardiology and Cardiovascular Medicine 1.1k
- Cancer Research 1.0k
Countries citing papers authored by Michel Farnier
This map shows the geographic impact of Michel Farnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Farnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Farnier more than expected).
Fields of papers citing papers by Michel Farnier
This network shows the impact of papers produced by Michel Farnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Farnier. The network helps show where Michel Farnier may publish in the future.
Co-authorship network of co-authors of Michel Farnier
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Farnier. A scholar is included among the top collaborators of Michel Farnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Farnier. Michel Farnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 77 | |
| 5 | 1 | |
| 6 | 11 | |
| 7 | 64 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 7 | |
| 11 | 56 | |
| 12 | ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemiabreakdown → | 418 |
| 13 | 12 | |
| 14 | 3 | |
| 15 | 8 | |
| 16 | 7 | |
| 17 | 45 | |
| 18 | 90 | |
| 19 | Ces dernières années | 1 |
| 20 | 18 |
About Michel Farnier
Michel Farnier is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research, having authored 196 papers that have together received 6.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (161 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (59 papers) and Cancer, Lipids, and Metabolism (45 papers). The work is most often cited by research in Surgery (4.9k citations), Endocrinology, Diabetes and Metabolism (1.7k citations) and Cancer Research (1.0k citations). Michel Farnier has collaborated with scholars based in France, United States and Italy. Frequent co-authors include John J.P. Kastelein, Michel Krempf, Gisle Langslet, Christelle Lorenzato, Jennifer G. Robinson, Maurizio Averna, Robert Pordy, Umesh Chaudhari, Frederick J. Raal and Gérald Luc. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.